The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential
Open accessAbstract
Rationale: Gut microbes influence cardiovascular disease and thrombosis risks through the production of trimethylamine N-oxide (TMAO). Microbiota-dependent generation of trimethylamine (TMA)—the precursor to TMAO—is rate limiting in the metaorganismal TMAO pathway in most humans and is catalyzed by several distinct microbial choline TMA-lyases, including the proteins encoded by the cutC/D (choline utilization C/D) genes in multiple human commensals. Objective: Direct demonstration that the gut microbial cutC gene is sufficient to transmit enhanced platelet reactivity and thrombosis potential in a host via TMA/TMAO generation has not yet been reported. Methods and Results: Herein, we use gnotobiotic mice and a series of microbial colonization studies to show that microbial cutC -dependent TMA/TMAO production is sufficient to transmit heightened platelet reactivity and thrombosis potential in a host. Specifically, we examine in vivo thrombosis potential employing germ-free mice colonized with either high TMA-producing stable human fecal polymcrobial communities or a defined CutC-deficient background microbial community coupled with a CutC-expressing human commensal±genetic disruption of its cutC gene (ie, Clostridium sporogenes Δ cutC ). Conclusions: Collectively, these studies point to the microbial choline TMA-lyase pathway as a rational molecular target for the treatment of atherothrombotic heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It has also been shown to promote platelet reactivity and thrombosis potential14, 83–85, vascular inflammation and inflammasome activation86–88, heightened heart failure89–91 and CKD92–95 related phenotypes in animal models (Figure 2).”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [14]
In the citing paper
“While only present at a very low abundance (only ~ 0.1%) within the large intestine gut microbial community, the gain-of-function C. sporogenes mutant elevated circulating TMA and TMAO levels within the host, and both enhanced rate of thrombus formation and reduced time to cessation of blood flow following arterial injury in vivo14.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [14]
In the citing paper
“Importantly, studies using germ-free mice colonized with synthetic microbial communities +/- a genetically engineered gain or loss of function cutC mutant human commensal confirmed that a functional microbial cutC gene is sufficient to transmit TMA and TMAO generation, as well as in vivo thrombosis potential.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [14]
In the citing paper
“Zhu et al. found that TMAO alters human platelet calcium signaling, heightening their responsiveness to sub-maximal stimulation by agonists (e.g. thrombin, ADP, collagen).”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [14]
In the citing paper
“Notably, however, TMAO levels appear to be driven more so by the gut microbial community composition than by the dietary intervention, and significant variation in TMAO production among individuals on a given diet is observed14, 111.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
McMurdie, P. J., & Holmes, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061217 · Cited by 21,942
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Self-citationMcDonald, D. T., Price, M. N., Goodrich, J. K., Nawrocki, E. P., DeSantis, T. Z., Probst, A. J., Andersen, G. L., Knight, R. D., & Hugenholtz, P. (2011) · The ISME Journal · doi:10.1038/ismej.2011.139 · Cited by 5,144
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Self-citation
Cited by
Sorted by citations
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Self-citationA Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors
Nemet, I., Saha, P. P., Gupta, N., Zhu, W., Romano, K. A., Skye, S. M., Cajka, T., Mohan, M. L., Li, L., Wu, Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.016 · Cited by 784
Self-citationRole and Mechanism of Gut Microbiota in Human Disease
Chen, Y., Zhou, J., & Wang, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.625913 · Cited by 695
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. Q. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 643
Intestinal Microbiota in Cardiovascular Health and Disease
Tang, W. H. W., Bäckhed, F., Landmesser, U., & Hazen, S. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.024 · Cited by 524
Self-citationInflamm-ageing: the role of inflammation in age-dependent cardiovascular disease
Liberale, L., Montecucco, F., Tardif, J., Libby, P., & Camici, G. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz961 · Cited by 363
Yang, S., Li, X., Yang, F., Zhao, R., Pan, X., Liang, J., Tian, L., Li, X., Liu, L., Xing, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01360 · Cited by 360
l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Koeth, R. A., Lam-Galvez, B. R., Kirsop, J., Wang, Z., Levison, B. S., Gu, X., Copeland, M. F., Bartlett, D., Cody, D. B., Dai, H. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94601 · Cited by 327
Self-citationGut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword
Peh, A., O’Donnell, J. A., Broughton, B. R. S., & Marques, F. Z. (2022) · Stroke · doi:10.1161/strokeaha.121.036800 · Cited by 260
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
Canyelles, M., Borràs, C., Rotllán, N., Tondo, M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031940 · Cited by 218
The gut microbiota and its interactions with cardiovascular disease
Xu, H., Wang, X., Feng, W., Liu, Q., Zhou, S., Liu, Q., & Cai, L. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13524 · Cited by 196
Cai, Y., Huang, F., Lao, X., Lu, Y., Gao, X. J., Alolga, R. N., Yin, K., Zhou, X., Wang, Y., Liu, B., et al. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00273-4 · Cited by 184
Gut microbes impact stroke severity via the trimethylamine N-oxide pathway
Zhu, W., Romano, K. A., Li, L., Buffa, J. A., Sangwan, N., Prakash, P., Tittle, A. N., Li, X. S., Fu, X., Androjna, C., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.002 · Cited by 167
Self-citationOrgan, C. L., Li, Z., Sharp, T. E., Polhemus, D. J., Gupta, N., Goodchild, T. T., Tang, W. H. W., Hazen, S. L., & Lefer, D. J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.016223 · Cited by 128
Self-citationCoronary artery disease is associated with an altered gut microbiome composition
Toya, T., Corban, M., Marietta, E. V., Horwath, I. E., Lerman, L. O., Murray, J. A., & Lerman, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227147 · Cited by 131
Nemet, I., Li, X. S., Haghikia, A., Li, L., Wilcox, J. D., Romano, K. A., Buffa, J. A., Witkowski, M., Demuth, I., König, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad333 · Cited by 131
Self-citationBuffa, J. A., Romano, K. A., Copeland, M. F., Cody, D. B., Zhu, W., Galvez, R., Fu, X., Ward, K., Ferrell, M., Dai, H. J., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-01010-x · Cited by 115
Self-citationHost hepatic metabolism is modulated by gut microbiota-derived sphingolipids
Le, H. H., Lee, M.-T., Besler, K. R., & Johnson, E. L. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.05.002 · Cited by 113
Winther, S. A., Oellgaard, J., Tofte, N., Tarnow, L., Wang, Z., Ahluwalia, T. S., Jorsal, A., Theilade, S., Parving, H., Hansen, T. W., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0048 · Cited by 111
Self-citationSimó, C., & García‐Cañas, V. (2020) · Food & Function · doi:10.1039/d0fo01237h · Cited by 112
Platelet Function in CKD: A Systematic Review and Meta-Analysis
Baaten, C. C. F. M. J., Sternkopf, M., Henning, T., Marx, N., Jankowski, J., & Noels, H. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020101440 · Cited by 102
Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure
Snelson, M., Muralitharan, R. R., Liu, C., Markó, L., Forslund, S. K., Marques, F. Z., & Tang, W. H. W. (2025) · Circulation Research · doi:10.1161/circresaha.125.325516 · Cited by 118
Self-citationGut microbiota and microbiota-derived metabolites in cardiovascular diseases
Chen, X., Zhang, H., Ren, S., Ding, Y.-N., Remex, N. S., Bhuiyan, M. S., Qu, J.-H., & Tang, X. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002206 · Cited by 101
Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice
Liu, Q., Cai, B.-Y., Zhu, L., Xin, X., Wang, X., An, Z., Li, S., Hu, Y., & Feng, Q. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118457 · Cited by 92
Lee, Y., Nemet, I., Wang, Z., Lai, H. T. M., Otto, M. C. D. O., Lemaître, R. N., Fretts, A. M., Sotoodehnia, N., Budoff, M. J., DiDonato, J. A., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020646 · Cited by 95
Self-citationTMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
Ye, Z., Lulu, C., Xiangchang, Z., Fang, Q., Binjie, Z., Chunyang, L., Rao, T., & Dongsheng, O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929262 · Cited by 91
Pathak, P., Helsley, R. N., Brown, A. L., Buffa, J. A., Choucair, I., Nemet, I., Baleanu‐Gogonea, C., Gogonea, V., Wang, Z., Garcı́a-Garcı́a, J. C., et al. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00584.2019 · Cited by 89
Self-citationInflammatory factors driving atherosclerotic plaque progression new insights
Song, B., Bie, Y.-L., Feng, H., Xie, B., Liu, M., & Zhao, F. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0012 · Cited by 85
Li, Z. H. (2024) · Gut · doi:10.1136/gutjnl-2024-331880 · Cited by 79
The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice
Kiouptsi, K., Jäckel, S., Pontarollo, G., Grill, A., Kuijpers, M. J. E., Wilms, E., Weber, C., Sommer, F., Nagy, M., Neideck, C., et al. (2019) · mBio · doi:10.1128/mbio.02298-19 · Cited by 70
Liu, C., Cheng, L., Ji, L., Li, F., Zhan, Y., Wu, B., Yang, K., Chen, P., Hua, F., Yuan, L., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.03.012 · Cited by 62
Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
Jing, L., Zhang, H., Xiang, Q., Shen, L., Guo, X., Zhai, C., & Hu, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.864600 · Cited by 69
The emerging role of gut microbial metabolism on cardiovascular disease
Kasahara, K., & Rey, F. E. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.09.007 · Cited by 59
Self-citationGut microbiota metabolites as integral mediators in cardiovascular diseases (Review)
Zhu, Y., Shui, X., Liang, Z., Huang, Z., Qi, Y., He, Y., Chen, C., Luo, H., & Lei, W. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4674 · Cited by 60
Wu, W., Panyod, S., Liu, P., Chen, C., Kao, H., Chuang, H.-L., Chen, Y., Zou, H.-B., Kuo, H., Kuo, C.-H., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00912-y · Cited by 58
Yang, J. J., Shu, X., Herrington, D. M., Moore, S. C., Meyer, K. A., Ose, J., Menni, C., Palmer, N. D., Eliassen, A. H., Harada, S., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa430 · Cited by 54
Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases
Xu, J., & Yang, Y. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1936379 · Cited by 61
Tan, C., Wang, H., Gao, X., Xu, R., Zeng, X., Cui, Z., Zhu, J., Wu, Q., Xia, G., Zhou, H., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00029 · Cited by 55
Goh, Y. Q., Cheam, G., & Wang, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03077 · Cited by 58
The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease
Hage, R. E., Al-Arawe, N., & Hinterseher, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032399 · Cited by 56
Jin, Q., Zhang, C., Chen, R., Jiang, L., Li, H., Wu, P., & Li, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05120-y · Cited by 55
Voigt, R. M., Wang, Z., Brown, J. M., Engen, P. A., Naqib, A., Goetz, C. G., Hall, D. A., Metman, L. V., Shaikh, M., Forsyth, C. B., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105780 · Cited by 51
Self-citationGut microbiota dependant trimethylamine N-oxide and hypertension
Mutengo, K. H., Masenga, S. K., Mweemba, A., Mutale, W., & Kirabo, A. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1075641 · Cited by 53
Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy
Dannenberg, L., Zikeli, D., Benkhoff, M., Ahlbrecht, S., Kelm, M., Levkau, B., & Polzin, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107584 · Cited by 47
The Influence of the Western Diet on Microbiota and Gastrointestinal Immunity
Heras, V. L., Melgar, S., MacSharry, J. A., & Gahan, C. G. M. (2022) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-052720-011032 · Cited by 53
Gut microbiota and their metabolites in cardiovascular disease
Jansen, V. L. B. I., Gerdes, V. E. A., Middeldorp, S., & van Mens, T. E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101492 · Cited by 50
Wang, Z., Kaplan, R. C., Burk, R. D., & Qi, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212337 · Cited by 48
Self-citationMetabolomic Profile in Venous Thromboembolism (VTE)
Franczyk, B., Gluba-Brzózka, A., Ławiński, J., Rysz-Górzyńska, M., & Rysz, J. (2021) · Metabolites · doi:10.3390/metabo11080495 · Cited by 42
Liu, G., Cheng, J., Zhang, T., Shao, Y., Chen, X., Han, L., Zhou, R., & Wu, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.856914 · Cited by 44
Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation
Iglesias‐Carres, L., Hughes, M. D., Steele, C. N., Ponder, M. A., Davy, K. P., & Neilson, A. P. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108600 · Cited by 43
Antibiotic Treatment Protocols and Germ-Free Mouse Models in Vascular Research
Bayer, F., Ascher, S., Pontarollo, G., & Reinhardt, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02174 · Cited by 44
Zhang, S., Jin, M., Ren, J., Sun, X., Zhang, Z., Luo, Y., & Sun, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114559 · Cited by 40
Gut Microbiota-Derived Metabolites in Atherosclerosis: Pathways, Biomarkers, and Targets
Tonch-Cerbu, A.-K., Boicean, A., Stoia, O., & Teodoru, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178488 · Cited by 46
Impact of trimethylamine N-oxide (TMAO) metaorganismal pathway on cardiovascular disease
Zhao, Y., & Wang, Z. (2020) · Journal of Laboratory and Precision Medicine · doi:10.21037/jlpm.2020.01.01 · Cited by 42
Self-citationFecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy Adults
Ferrell, M., Bazeley, P. S., Wang, Z., Levison, B. S., Li, X. S., Jia, X., Krauss, R. M., Knight, R. D., Lusis, A. J., Garcı́a-Garcı́a, J. C., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021934 · Cited by 39
Self-citationWilcox, J. D., Skye, S. M., Graham, B., Zabell, A., Li, X. S., Li, L., Shelkay, S., Fu, X., Neale, S., OʼLaughlin, C., et al. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.03.016 · Cited by 44
Self-citationXie, Z., Liu, X., Huang, X., Liu, Q., Yang, M., Huang, D., Zhao, P., Tian, J., Wang, X., & Hou, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174526 · Cited by 36
Yi, Z.-Y., Peng, Y., Hui, B.-P., Liu, Z., Lin, Q.-X., Zhao, D. S., Wang, Y., Liu, X., Xie, J., Zhang, S., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154775 · Cited by 40
The gut microbiota in thrombosis
Khuu, M. P., Paeslack, N., Dremova, O., Benakis, C., Kiouptsi, K., & Reinhardt, C. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01070-6 · Cited by 36
Gut Microbiota and Environment in Coronary Artery Disease
Piccioni, A., de Cunzo, T., Valletta, F., Covino, M., Rinninella, E., Raoul, P. C., Zanza, C., Mele, M. C., & Franceschi, F. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084242 · Cited by 34
Papadopoulos, P., Tsigalou, C., Valsamaki, P. N., Konstantinidis, T. G., Voidarou, C. C., & Bezirtzoglou, E. (2022) · Biomedicines · doi:10.3390/biomedicines10050948 · Cited by 40
Haas, E. A., Saad, M. J. A., Santos, A., Vitulo, N., Lemos, W. J. F., Martins, A. M. A., Picossi, C. R. C., Favarato, D., Gaspar, R. S., Magro, D. O., et al. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac286 · Cited by 33
Amrein, M., Li, X. S., Walter, J. E., Wang, Z., Zimmermann, T., Strebel, I., Honegger, U., Leu, K., Schäfer, I., Twerenbold, R., et al. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-01992-6 · Cited by 34
Self-citationHuang, K., Li, Z., He, X., Dai, J., Huang, B., Shi, Y., Fan, D., Zhang, Z., Liu, Y., Li, N., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.014 · Cited by 32
The Gut Microbiota in Cardiovascular Disease and Arterial Thrombosis
Lässiger-Herfurth, A., Pontarollo, G., Grill, A., & Reinhardt, C. (2019) · Microorganisms · doi:10.3390/microorganisms7120691 · Cited by 32
Kanmani, S., Son, T., Kim, K., & Koo, B. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104583 · Cited by 31
Li, Z., Gu, M., Zaparte, A., Fu, X., Mahen, K. K., Mrdjen, M., Li, X. S., Yang, Z., Ma, J., Thoudam, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55084-2 · Cited by 34
Self-citationJaworska, K., Kopacz, W., Koper, M., & Ufnal, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312511 · Cited by 32
Li, N., Wang, L., Li, L., Yang, M.-Z., Wang, Q., Bai, X., Gao, F., Yuan, Y., Yu, Z., & Ren, Z. (2023) · Military Medical Research · doi:10.1186/s40779-023-00489-1 · Cited by 32
Trimethylamine N-oxide—a marker for atherosclerotic vascular disease
Xie, G., An, Y., Lin, P., Wang, Y., & Guo, L. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2203085 · Cited by 27
Intestinal Flora: A Potential New Regulator of Cardiovascular Disease
Zou, Y., Song, X., Liu, N., Sun, W., & Liu, B. (2022) · Aging and Disease · doi:10.14336/ad.2021.1022 · Cited by 27
Heinrich‐Sanchez, Y., & Vital, M. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2525403 · Cited by 27
TMAO: a potential mediator of clopidogrel resistance
Ma, R., Fu, W., Zhang, J., Hu, X., Yang, J., & Jiang, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-85950-8 · Cited by 25
Goulding, D. R., Myers, P., Dickerson, A. B., Comins, M. M., Wiltshire, R. A., & Blankenship-Paris, T. L. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-21-000023 · Cited by 24
Enterobacter aerogenes ZDY01 inhibits choline-induced atherosclerosis through CDCA-FXR-FGF15 axis
Tang, J., Qin, M., Tang, L. M., Shan, D., Zhang, C., Zhang, Y., Wei, H., Qiu, L., & Yu, J. (2021) · Food & Function · doi:10.1039/d1fo02021h · Cited by 26
A Bibliometric Analysis of Research on the Links Between Gut Microbiota and Atherosclerosis
Wang, Y., Li, D., Jia, Z., Hui, J., Xin, Q., Zhou, Q., Cong, W., & Xu, F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.941607 · Cited by 25
Microbe-derived uremic solutes enhance thrombosis potential in the host
Nemet, I., Funabashi, M., Li, X. S., Dwidar, M., Sangwan, N., Skye, S. M., Romano, K. A., Čajka, T., Needham, B. D., Mazmanian, S. K., et al. (2023) · mBio · doi:10.1128/mbio.01331-23 · Cited by 24
Self-citationGuo, M., Fang, L., Chen, M., Shen, J., Tan, Z., & He, W. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1354823 · Cited by 24
Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke
Li, Z., He, X., Fang, Q., & Yin, X. (2024) · Biomolecules · doi:10.3390/biom14111463 · Cited by 26
Zhang, X., Zhang, X., Tong, F., Cai, Y., Zhang, Y., Song, H., Tian, X., Yan, C., & Han, Y. (2022) · eLife · doi:10.7554/elife.70240 · Cited by 24
Gajger, I. T., & Cvetkovikj, A. (2025) · Antioxidants · doi:10.3390/antiox14091086 · Cited by 24
Davies, A. J., Wenzl, F. A., Li, X. S., Winzap, P., Obeid, S., Klingenberg, R., Mach, F., Räber, L., Müller, O., Matter, C. M., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131261 · Cited by 21
Self-citationPro-Inflammatory Food, Gut Microbiota, and Cardiovascular and Pancreatic Diseases
Chen, B., Patel, S., Bao, L., Nadeem, D., & Krittanawong, C. (2024) · Biomolecules · doi:10.3390/biom14020210 · Cited by 18
Crosstalk between the Gut and Brain in Ischemic Stroke: Mechanistic Insights and Therapeutic Options
Huang, W., Zhu, L., Song, W., Zhang, M., Teng, L., & Wu, M. (2022) · Mediators of Inflammation · doi:10.1155/2022/6508046 · Cited by 18
Avilés‐Jiménez, F. (2022) · BioMed Research International · doi:10.1155/2022/9943158 · Cited by 19
Analyzing Immune Cell Infiltration and Copper Metabolism in Diabetic Foot Ulcers
Yi, W.-J., Yuan, Y., Bao, Q., Zhao, Z., Ding, H.-S., & Song, J. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s452609 · Cited by 18
Human Gut Microbiota in Cardiovascular Disease
Ronen, D., Rokach, Y., Abedat, S., Qadan, A., Daana, S., Amir, O., & Asleh, R. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230012 · Cited by 28
Organic cation transporters 2: Structure, regulation, functions, and clinical implications
Ailabouni, A. S., & Prasad, B. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100044 · Cited by 17
Zhu, X., Zhao, L., Wang, Y., Hu, X., Zhu, Y., & Yang, X. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.129179 · Cited by 17
Gut Microbiota and the MicrovasculaturePreprint
Kiouptsi, K., Pontarollo, G., & Reinhardt, C. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041179 · Cited by 17
The effect of TMAO on aging-associated cardiovascular and metabolic pathways and emerging therapies
Alsulami, M., Alamri, H. S., Barhoumi, T., Munawar, N., & Alghanem, B. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05356-2 · Cited by 18
Mehta, V., Nagu, P., Inbaraj, B. S., Sharma, M., Parashar, A., & Sridhar, K. (2022) · Bioengineering · doi:10.3390/bioengineering9120798 · Cited by 17
Gut microbiota and stroke: New avenues to improve prevention and outcome
Clottes, P., Benech, N., Dumot, C., Jarraud, S., Vidal, H., & Mechtouff, L. (2023) · European Journal of Neurology · doi:10.1111/ene.15770 · Cited by 16
Exploratory Transcriptomic Profiling Reveals the Role of Gut Microbiota in Vascular Dementia
Kaur, N., LaForce, G. R., Mallela, D. P., Saha, P. P., Buffa, J. A., Li, X. S., Sangwan, N., Rothenberg, K. G., & Zhu, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098091 · Cited by 16
Self-citationThe Involvement of Immune Cells Between Ischemic Stroke and Gut Microbiota
Pu, B., Zhu, H., Wei, L., Gu, L., Zhang, S., Jian, Z., & Xiong, X. (2023) · Translational Stroke Research · doi:10.1007/s12975-023-01151-7 · Cited by 16
Human Gut Microbiome Researches Over the Last Decade: Current Challenges and Future Directions
Wu, H., Forslund, S. K., Wang, Z., & Zhao, G. (2023) · Phenomics · doi:10.1007/s43657-023-00131-z · Cited by 18
Self-citationResearch development on gut microbiota and vulnerable atherosclerotic plaque
Zheng, S., Liu, Z., Liu, H., Lim, J. Y., Li, D. W. H., Zhang, S., Luo, F., Wang, X., Sun, C., Tang, R., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25186 · Cited by 18
Gut‒heart axis: emerging therapies targeting trimethylamine N-oxide production
Torres, E. R., Wilcox, J. D., & Tang, W. H. W. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2604868 · Cited by 18
Self-citationHan, S., Cai, L., Chen, P., & Kuang, W. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1191758 · Cited by 18
The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV
Peters, B. A., Burk, R. D., Kaplan, R. C., & Qi, Q. (2023) · Current HIV/AIDS Reports · doi:10.1007/s11904-023-00648-y · Cited by 16
Metadata
- Authors
- Skye, S. M., Zhu, W., Romano, K. A., Guo, C.-J., Wang, Z., Jia, X., Kirsop, J., Haag, B., Lang, J. M., DiDonato, J. A., Tang, W. H. W., Lusis, A. J., Rey, F. E., Fischbach, M. A., & Hazen, S. L.
- Affiliations
- Cleveland Clinic (US)
- University of California, Los Angeles (US)
- University of Wisconsin–Madison (US)
- ORCID
- Venue
- Circulation Research
- Published
- 2018-10-26
- Volume
- 123
- Issue
- 10
- Pages
- 1164-1176
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC6223262
- OpenAlex
- W2898598580
- Cited by
- 189
- References
- 48
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 24 · 2023: 27 · 2022: 31 · 2021: 28 · 2020: 21 · 2019: 11 · 2018: 2
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (1s10od016346-01a1, 5t32dk007470-35)
- National Heart, Lung, and Blood Institute (P01HL030568, R01HL126827, T32HL134622, R01HL103866)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK110174, DP1DK113598, R01DK106000, R01DK108259, T32-DK 007470, R01DK101674)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- gut microbiota, trimethylamine N-oxide, trimethylamine, platelet reactivity, thrombosis, Clostridium sporogenes, gnotobiotic mice, microbial colonization, cardiovascular risk
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Adult, Animals, Bacterial Proteins, Choline, Clostridium, Female, Humans, Lyases, Male, Methylamines, Mice, Inbred C57BL, Middle Aged, Thrombosis, Platelet Activation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
